瑞康医药：累计回购公司股份2044.6517万股

Group 1 - The core point of the article is that Ruikang Pharmaceutical announced a share buyback plan, intending to repurchase 20.446517 million shares, which represents 1.36% of the company's total share capital as of July 31, 2025 [1]